Compounds > pinocembrin

Page last updated: 2024-08-24

pinocembrin and kaempferol

pinocembrin has been researched along with kaempferol in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CJ; Geahlen, RL	1
Habtemariam, S	1
Bremer, R; Holder, S; Lilly, MB; Neidigh, JW; Tabrizizad, M; Zemskova, M; Zhang, C	1
Brown, ML; Holder, S; Lilly, M	1
Hashimoto, K; Hasumi, K; Koshino, H; Takahashi, S; Tani, H; Tatefuji, T	1
Itoh, T; Sakakibara, H; Shimoi, K; Takemura, H; Yamamoto, K	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM	1

Reviews

1 review(s) available for pinocembrin and kaempferol

Article	Year
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. Journal of natural products, 1992, Volume: 55, Issue:11 Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases	1992

Other Studies

7 other study(ies) available for pinocembrin and kaempferol

Article	Year
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. Journal of natural products, 1997, Volume: 60, Issue:8 Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1997
Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Molecular cancer therapeutics, 2007, Volume: 6, Issue:1 Topics: Chromones; Crystallography, X-Ray; Flavones; Flavonoids; Humans; Male; Phenotype; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein Structure, Secondary; Proto-Oncogene Proteins c-pim-1; Sensitivity and Specificity; Substrate Specificity	2007
Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase. Bioorganic & medicinal chemistry, 2007, Oct-01, Volume: 15, Issue:19 Topics: Binding Sites; Computer Simulation; Databases, Factual; Drug Design; Enzyme Inhibitors; Flavonoids; Humans; Ligands; Models, Molecular; Predictive Value of Tests; Proto-Oncogene Proteins c-pim-1; Quantitative Structure-Activity Relationship; Static Electricity; Stereoisomerism	2007
Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes. Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1 Topics: Animals; Anti-Allergic Agents; Bees; Cell Line, Tumor; Cysteine; Histamine; Humans; Leukocytes; Leukotrienes; Propolis; Rhinitis, Allergic, Seasonal	2010
Selective inhibition of methoxyflavonoids on human CYP1B1 activity. Bioorganic & medicinal chemistry, 2010, Sep-01, Volume: 18, Issue:17 Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Humans; Models, Molecular; Structure-Activity Relationship	2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. Journal of natural products, 2015, Nov-25, Volume: 78, Issue:11 Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship	2015